Shares of renewable fuels company Gevo Inc. (GEVO) took a dive in Thursday's premarket session. The reason? The company just pulled out of the running for a loan guarantee from the U.S. Department of Energy for its ATJ-30 project.

The Financing Pivot

So, what happened? According to Gevo, the DOE wanted the project to support something called enhanced oil recovery. The company says that's just not a commercially viable option at scale in the project area right now. Instead of trying to fit a square peg into a round hole, Gevo decided to walk away and look for other money.

The plan now is to find alternative financing that's a better fit for the company's strategy, which it hopes will speed things up and improve returns. The good news is that withdrawing doesn't mean the door is slammed shut forever; Gevo can reapply for DOE financing later if it wants to.

The Project Marches On

Here's the important part: the project itself isn't stopping. Gevo had been trying to move a prior conditional DOE loan guarantee—originally for a different sustainable aviation fuel project in South Dakota—over to this ATJ-30 project at its facility in North Dakota. That effort is now off the table, but work on ATJ-30 continues.

The North Dakota site is where Gevo is working on low-carbon ethanol production and carbon capture. The company says this facility is already bringing in cash and can support growth in earnings before interest, taxes, depreciation, and amortization (EBITDA). It's also supposed to be the foundation for expanding the sustainable fuels business.

What the CEO Says

CEO Paul Bloom put a positive spin on the move. "Over the past year, we have substantially derisked our position in low-carbon ethanol required for our ATJ and we believe we are in a better position to secure alternative financing that allows us to pursue the most accretive business case in alignment with company strategy and timelines," he said.

In other words, they've made their core ethanol business less risky and now think they can get better financing elsewhere. Bloom also highlighted that the North Dakota site is already a money-maker.

A Look at the Market's Mood

The market's immediate reaction was to sell. Gevo shares were down 16.00% at $1.68 in premarket trading Thursday. Interestingly, while the stock was getting hit, the number of investors betting against it—the short interest—actually fell a bit. It dropped to 30.33 million shares from 31.53 million, which is about 12.64% of the stock's public float. At the recent average trading volume, it would take short sellers roughly 6.6 days to buy back all their borrowed shares and close their positions.

Reading the Charts

A quick technical checkup shows the stock is in a rough patch. It's trading 19% below its 20-day average and 12.4% below its 50-day average, which points to bearish short-term momentum. It's also 7% below its 200-day average, suggesting a longer-term downtrend. The relative strength index (RSI) sits at 42.17, which is in neutral territory—no extreme buying or selling pressure here.

Traders are watching a couple of key levels. The $2.00 mark has been a spot where selling tends to pick up (resistance), while $1.50 is seen as a critical floor that could signal a reversal if the price tests it (support).

Despite the recent slide, it's worth noting that over the past 12 months, Gevo's stock is still up a whopping 70.94%.

What's Next: Earnings and What the Experts Think

All eyes will be on the company's next financial update, expected around May 12, 2026. Analysts are forecasting a loss of 2 cents per share, which is an improvement from a loss of 9 cents a year ago. Revenue is expected to jump to $44.94 million from $29.11 million.

Perhaps surprisingly given the stock's drop, the analyst community is still pretty bullish. The consensus rating is a Strong Buy, with an average price target of $4.69. Here's a snapshot of some recent analyst moves:

• Northland Capital Markets: Outperform rating, maintains a $3.00 price target (as of Dec. 31, 2025).
• UBS: Neutral rating, raised its price target to $2.25 (as of Sept. 17, 2025).
• HC Wainwright & Co.: Buy rating, maintains a $14.00 price target (as of May 30, 2025).

So, the story here is a financing detour that spooked traders today, but the company insists its roadmap is still clear and the experts on Wall Street haven't lost faith in the long-term destination.